Publication | Closed Access

The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats

Hemiparkinsonian RatsGlutamate Antagonist AmantadineNeurophysiologyMedicinePsychotropic MedicationNeuropharmacologyPharmacotherapyNeurologyNeuroscienceL-dopa-induced DyskinesiaDopaminePharmacologySocial SciencesDopamine Research